| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Xiaoying Liu CEO | XSHE Exchange | CNE100003308 ISIN |
| CN Country | 1,384 Employees | 4 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Founded in 1996 and based in Chongqing, China, Chongqing Pharscin Pharmaceutical Co., Ltd. is a versatile pharmaceutical company involved in the comprehensive processes of research and development, production, and sale of diverse drugs within the Chinese market. The company is committed to addressing various medical needs, particularly specializing in the realm of CNS (Central Nervous System), digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular diseases. Through a commitment to innovation and quality, Chongqing Pharscin Pharmaceutical stands as a significant player in the pharmaceutical industry of China.
Chongqing Pharscin Pharmaceutical Co., Ltd. offers a wide range of pharmaceutical products and services, including:
By providing a broad spectrum of pharmaceutical products, Chongqing Pharscin Pharmaceutical aims to cater to diverse healthcare needs, focusing on the treatment of critical and common conditions.